Lilly’s Donanemab receives CDSCO approval for treatment of Alzheimer’s disease
Eli Lilly and Company (India) announced that the Central Drugs Standard Control Organization (CDSCO) has granted…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alzheimer
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says…
Leqembi is the only approved treatment in China that has shown efficacy in slowing the progression of Alzheimer’s by directly…
Biogen scraps two late-stage trials for Alzheimer’s treatment
The decision was based on the results of a review conducted by a data safety monitoring board, which recommended discontinuing the…
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
‘Mass Spectrometry helps in better understanding of diseases like Alzheimer’s and Parkinson’s’
Dr David Smith, course leader for MSc Biotechnology and senior lecturer in biochemistry, Sheffield Hallam University, UK talks…
Suven Life secures five product patents
The granted claims of the patents include the class of selective 5-HT compounds and are being developed as therapeutic agents
Neuropsychological, neuropsychiatric help follow course of Alzheimer’s disease
Difficulties in cognitive performance were not linked to behavioural and psychological problems